(Q39201293)

9 September 2017

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions (English)

1 reference

9 September 2017

1 reference

Martina Kluth

1

1 reference

9 September 2017

Jana Hesse

2

1 reference

9 September 2017

Anna Heinl

3

1 reference

9 September 2017

Antje Krohn

4

1 reference

9 September 2017

Stefan Steurer

5

1 reference

9 September 2017

Hüseyin Sirma

6

1 reference

9 September 2017

Ronald Simon

7

1 reference

9 September 2017

Pascale-Sophia Mayer

8

1 reference

9 September 2017

Udo Schumacher

9

1 reference

9 September 2017

Katharina Grupp

10

1 reference

9 September 2017

Jakob R Izbicki

11

1 reference

9 September 2017

Klaus Pantel

12

1 reference

9 September 2017

Ekkehard Dikomey

13

1 reference

9 September 2017

Jan O Korbel

14

1 reference

9 September 2017

Christoph Plass

15

1 reference

9 September 2017

Guido Sauter

16

1 reference

9 September 2017

Thorsten Schlomm

17

1 reference

9 September 2017

Sarah Minner

18

1 reference

9 September 2017

1 February 2013

1 reference

9 September 2017

1 reference

9 September 2017

26

1 reference

9 September 2017

7

1 reference

9 September 2017

975-983

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2012.236

9 September 2017

0 references

cites work

DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Suppression of Tak1 promotes prostate tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

TGF-beta activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Opposing effects of Wnt and MAPK on BMP/Smad signal duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

TAK1 regulates cartilage and joint development via the MAPK and BMP signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Signal transduction by the JNK group of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Mechanisms and functions of p38 MAPK signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

FISH Oracle: a web server for flexible visualization of DNA copy number data in a genomic context.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Integrative genomic approaches identify IKBKE as a breast cancer oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Ubiquitylation and cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Downregulation of gap junctions in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

The genomic complexity of primary human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Haplo-insufficiency: a driving force in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Genome interrupted: sequencing of prostate cancer reveals the importance of chromosomal rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

SWI/SNF nucleosome remodellers and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

7 January 2021

Genetic pattern of prostate cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

7 January 2021

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

7 January 2021

Differential p53-independent outcomes of p19(Arf) loss in oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.236

7 January 2021

10.1038/MODPATHOL.2012.236

Identifiers

DOI

1 reference

9 September 2017

1 reference